✦ LIBER ✦

Sa1237 Prediction of Primary Response to Infliximab in Crohn's Disease: A Matrix-Based Prediction Model

✍ Scribed by Billiet, Thomas; de Bruyn, Magali; Ballet, Vera; Claes, Karolien; Liu, Xinjun; Kirkland, Richard; Drake, Katherine; Lockton, Steven; Princen, Fred; Singh, Sharat; Ferrante, Marc; van Assche, Gert A.; Rutgeerts, Paul J.; Cleynen, Isabelle; Vermeire, Severine

Book ID: 122108787
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 201 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60841-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P566 A matrix-based prediction model for

P566 A matrix-based prediction model for primary response to infliximab in Crohn's disease patients

✍ Billiet, T.; de Bruyn, M.; Claes, K.; Ballet, V.; Liu, X.; Kirkland, R.; Drake, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 140 KB

Prediction of response to infliximab in

Prediction of response to infliximab in Crohn's disease

✍ R. Chaudhary; S. Ghosh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Are systemic inflammatory markers useful

Are systemic inflammatory markers useful in the prediction of response to infliximab in Crohn's disease?

✍ Louis, Edouard J.; Vermeire, Severine; Rutgeerts, Paul; De Vos, Martine; Van Gos 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Predictive value of epithelial gene expr

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease

✍ Ingrid Arijs; Roel Quintens; Leentje Van Lommel; Kristel Van Steen; Gert De Hert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Background: Infliximab (IFX) has become the mainstay of therapy of refractory Crohn's disease (CD). However, a subset of patients shows incomplete or no response to this agent. In this study we investigated whether we could identify a mucosal gene panel to predict (non)response to IFX in CD. Method

Sa1231 Elevated Serum IL-17 Levels in Cr

Sa1231 Elevated Serum IL-17 Levels in Crohn's Disease Correlate With Disease Activity but Do Not Predict Response to Infliximab

✍ Abhyankar, Anita; Ham, Maggie; Bai, Aiping; Cheifetz, Adam S.; Robson, Simon C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 222 KB

P360 Infliximab trough levels may predic

P360 Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease: A single cohort study

✍ M. Bortlik; D. Duricova; K. Malickova; A. Komarek; N. Machkova; E. Bouzkova; L. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 49 KB